Applied Genetics Appoints Dr. Milici Interim President
News Jan 10, 2012
Dr. Tony Milici, GeneThera, Inc.'s CEO, stated, "My appointment as Interim President of Applied Genetics represents the first step in the reorganization of our Mexico Company. After several challenging years trying to start this business, we finally have both the financial and marketing support to move forward. It is my intention to move swiftly through the reorganization process in order to initiate Applied Genetics' commercial and revenue generating operation as quickly as possible."
Johne's disease is a global devastating and incurable disease of dairy cows, sheep and goats caused by a bacterium called Mycobacterium Paratuberculosis sub. Avium, (MAP). An overwhelming number of evidences have shown that MAP is the causative agent of Crohn's disease in humans. Dairy products, contaminated with MAP, are the vehicles by which the infection spreads in the human intestine. Applied Genetics employs the use of GeneThera HerdCheck™ to test and control the spread of Johne's disease in Mexico.
HerdCheck™ is a proprietary molecular diagnostic system based on the use of high throughput robotics and Real time PCR.